ALIOF:
Analysis & Opinions
-
February 15, 2013
Switzerland-based Actelion Ltd. (ALIOF) reported fourth quarter 2012 earnings of 47 cents per American Depository ...
-
December 26, 2012
Actelion (ALIOF) recently announced that it is moving forward with phase III development of cadazolid in patients ...
-
December 19, 2012
Actelion (ALIOF) recently announced positive results from a phase II study on its S1P1 modulator, ponesimod. ...
-
December 18, 2012
Switzerland-based Actelion (ALIOF) recently announced that the US Food and Drug Administration (FDA) accepted its ...
-
November 26, 2012
The European Medicines Agency (EMA) recently accepted the Marketing Authorisation Application (MAA) filed by ...
-
November 08, 2012
Auxilium Pharmaceuticals, Inc. (AUXL) reported a loss of 21 cents per share in the third quarter of 2012, wider than ...
-
October 29, 2012
Switzerland-based Actelion (ALIOF) recently submitted a New Drug Application (NDA) to the US Food and Drug ...
-
October 19, 2012
Switzerland-based Actelion (ALIOF) reported third quarter 2012 earnings of $1.17 per American Depository Receipt ...
-
October 15, 2012
Arena Pharmaceuticals, Inc. (ARNA) recently initiated a phase I multiple dose study with APD811, which is being ...
-
September 11, 2012
Switzerland-based Actelion (ALIOF) recently declared that it has implemented the cost saving initiative announced by ...
-
August 21, 2012
Mylan Inc. (MYL) recently announced that its UK and Italian subsidiaries have launched its generic version of ...
-
August 02, 2012
Auxilium Pharmaceuticals, Inc. (AUXL) swung to a profit in the second quarter of 2012 with earnings coming in at 16 ...
-
July 20, 2012
Switzerland-based Actelion (ALIOF) reported second quarter 2012 earnings of $1.56 per American Depository Receipt ...
-
July 12, 2012
Switzerland-based Actelion (ALIOF) recently announced that approximately 135 employees of the company could be shown ...
-
July 10, 2012
Auxilium Pharmaceuticals, Inc.'s (AUXL) Xiaflex recently gained approval in yet another country. Auxilium Pharma and ...
-
June 07, 2012
Mylan Pharmaceuticals ULC., the Canadian subsidiary of generic company, Mylan Inc. (MYL), recently announced that it ...
